| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.50.4.1136 |
| P953 | full work available online at | https://www.neurology.org/doi/pdfdirect/10.1212/WNL.50.4.1136 |
| P698 | PubMed publication ID | 9566408 |
| P50 | author | Donato A Di Monte | Q83119182 |
| P2093 | author name string | J. W. Langston | |
| X. Jiang | |||
| P. Chan | |||
| L. S. Forno | |||
| C. M. Tanner | |||
| P2860 | cites work | Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity | Q36022813 |
| Annals of Neurology | Q564414 | ||
| neurodegeneration | Q1755122 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Synuclein | Q24767155 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 1136-1137 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease | |
| Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease | |||
| P478 | volume | 50 |
| Q34426172 | Alpha-synuclein and dopamine metabolism |
| Q36677512 | Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein |
| Q35681844 | Chasing genes in Alzheimer's and Parkinson's disease |
| Q77365028 | Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation |
| Q35462051 | Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease |
| Q73011812 | Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism |
| Q31961819 | Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism |
| Q33714108 | Etiology of Parkinson's disease |
| Q40549467 | Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons |
| Q48620817 | Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease. |
| Q44195128 | Genetic epidemiology of Parkinson's disease |
| Q24558967 | Genetics of Parkinson disease |
| Q37037053 | Genetics of Parkinson disease |
| Q37361830 | Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations |
| Q90599546 | Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease |
| Q64763010 | Impact of gene mutation in the development of Parkinson's disease |
| Q34802076 | MPTP: insights into parkinsonian neurodegeneration |
| Q24320119 | Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress |
| Q40260539 | Multisystem Lewy body disease and the other parkinsonian disorders |
| Q83920682 | Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease |
| Q40627442 | Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity |
| Q34169019 | Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra |
| Q33337881 | Parkinson's disease: current and future challenges |
| Q37350181 | Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys |
| Q39998122 | RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability |
| Q30626337 | Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data |
| Q34663590 | The Synuclein Family |
| Q43798526 | The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein |
| Q82029342 | The neuropathology of parkinsonism |
| Q34048136 | The pathogenesis of multiple system atrophy: past, present, and future |
| Q26799590 | Using iPS Cells toward the Understanding of Parkinson's Disease |
Search more.